The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to help more patients.

Idorsia US was established in 2020 to drive the company into a new phase and realize our ambition of bringing innovative medicines from bench to bedside.

With commercial operations based outside of Philadelphia, PA, one of densest communities of life sciences talent in the world, our goal is to build the commercial footprint that will deliver Idorsia’s deep pipeline of products from its drug discovery engine to the US market – changing the lives of many patients. We have assembled a diverse and highly regarded leadership team, with decades of experience across therapeutic areas.

We think big, and we go big. Our aim is to deliver at least three products to market in the next five years.


We have identified five key strategic priorities to ensure the company’s success over the first five years.


Idorsia’s corporate responsibility efforts encompass employee development and diversity, governance and ethics, as well as the organization’s economic, environmental, and social performance.


It’s the Idorsia team’s passion for science that will translate our objectives into value creation for all our stakeholders.

Research & Development

Idorsia aims to deliver new products with the potential to significantly change the treatment options in their target diseases.